Source: Veterinary Pharmaceutical Solutions news release
ST. PETER, Minn. – Veterinary Pharmaceutical Solutions (VPS), a market leader in livestock pharmacy compounding, announced two extraordinary milestones in the company’s history: The completion of a pharmacy expansion in St. Peter, Minnesota, and the company’s 30th anniversary.
The pharmacy expansion nearly doubles the size of the existing facility and is designed to be the highest quality compounding pharmacy in the industry. It features multiple state-of-the-art compounding suites to advance current solutions and develop new products, space to expand R&D, a microbiology lab and warehouse space. All of these features enable VPS to elevate its operations and more quickly create innovative solutions for veterinarian and producer customers.
“As we celebrate 30 years of innovation, this expansion is really about listening to the needs of our customers and providing solutions,” said Dean Warras, CEO of Veterinary Pharmaceutical Solutions. “Every part of the addition–from the new compounding suites to the R&D and microbiology labs–is designed to help us deliver even greater quality, innovation and solutions to meet the evolving needs of the livestock and poultry industries.”
“We’re proud to be part of the growth and expansion of VPS and to support this significant expansion,” says James Clark, partner at Granite Creek Capital Partners, the investment firm that backed the project. “We recognize the value and innovation that VPS brings to the marketplace and are eager to be a partner in those efforts.”
With this expansion VPS continues to grow its capability in animal drug compounding, a critical service that allows for the customization of medications to address distinct animal health requirements. The expansions, with FDA oversight, adhere to further national standards and align with state Boards of Pharmacy in their respective areas of operation.
“This expansion gives us space to install new equipment and allows for the complete segregation of customized medicines where needed,” said Stacy Peters, Chief Commercial Officer. “We can research non-traditional approaches to developing new and effective compounded solutions for challenges our veterinarians and producer customers are seeing on farm.”
VPS broke ground on the pharmacy expansion on August 1, 2024, and received occupancy approval from the Minnesota Board of Pharmacy for the new space on April 1, 2025.
About Veterinary Pharmaceutical Solutions
Veterinary Pharmaceutical Solutions (VPS) is a Minnesota-based 503A licensed compounding pharmacy dedicated to providing innovative animal health solutions to the veterinary community. VPS provides a comprehensive range of livestock and poultry compounded and antibiotic-free products, including UltrAmox, Meloxicam, Iversol, Mendicin, Healicin ABF, and UltraFlor. VPS specializes in creating customized medications tailored to the unique needs of individual animals or groups of animals, always under the direct supervision of a veterinarian.
